Skip to main content

Table 1 Comparison of demographic, comorbidity, and clinical characteristics of CAPA group and non-fungal infection group

From: Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant

Variables

CAPA

(n = 168)

Non-fungal infection

(n = 168)

P

Male, n (%)

124 (73.8)

118 (70.2)

0.544

Age, years

74.5 (62.0 ~ 83.0)

71.0 (59.0 ~ 82.0)

0.367

Smoking history, n (%)

40 (23.8)

20 (11.9)

0.007

History of alcohol consumption, n (%)

20 (11.9)

17 (10.1)

0.728

Comorbidity, n (%)

 

Hypertension

91 (54.2)

79 (47.0)

0.230

Diabetes

46 (27.4)

39 (23.2)

0.452

Coronary artery disease

42 (25.0)

22 (13.1)

0.008

Chronic obstructive pulmonary disease

22 (13.1)

9 (5.4)

0.022

Cerebrovascular disease

24 (14.3)

19 (11.3)

0.514

Malignancy

30 (17.9)

20 (11.9)

0.167

Chronic renal insufficiency

21 (12.5)

10 (6.0)

0.058

HIV infection

2 (1.2)

0 (0)

0.499

Immunocompromised status

32 (19.0)

24 (14.3)

0.306

First symptoms

 

Fever (temperature ≥ 37.0℃), n (%)

147 (87.5)

133 (79.2)

0.056

Maximum temperature, ℃, median (IOR)

38.8 (38.2 ~ 39.5)

38.9 (38.0 ~ 39.2)

0.178

Cough, n (%)

135 (80.4)

145 (86.3)

0.187

Expectoration, n (%)

119 (70.8)

118 (70.2)

1.000

Chest tightness, n (%)

69 (41.1)

51 (30.4)

0.053

Shortness of breath, n (%)

80 (47.6)

38 (22.6)

< 0.001

Fatigue, n (%)

91 (54.2)

69 (41.1)

0.022

Myalgia, n (%)

5 (3.0)

28 (16.7)

< 0.001

Nasal congestion, runny nose, n (%)

12 (7.14)

10 (6.0)

0.826

Nausea, vomiting, n (%)

13 (7.7)

14 (8.3)

1.000

Abdominal pain, diarrhea, n (%)

19 (11.3)

12 (7.1)

0.258

Vital signs on admission

 

Systolic blood pressure, mmHg

128.9 ± 22.6

128.4 ± 18.5

0.826

Diastolic blood pressure, mmHg

74.1 ± 12.7

73.7 ± 10.6

0.768

Heart rate, beats/min

88.6 ± 19.1

87.6 ± 17.2

0.593

Respiratory rate, breaths/min

20.0 (18.0 ~ 22.0)

20.0 (19.0 ~ 20.0)

0.806

Body temperature, ℃

36.5 (36.3 ~ 36.8)

36.5 (36.3 ~ 36.8)

0.771

Severity of illness at admission, n (%)

 

Mild and moderate

111 (66.1)

120 (71.4)

0.346

Severe and critical

57 (33.9)

48 (28.6)

Severity of illness at worst, n (%)

 

Mild and moderate

30 (17.9)

97 (57.7)

< 0.001

Severe and critical

138 (82.1)

71 (42.3)

  1. Bolded terms represent subheadings. Bold values represent p < 0.05, indicating statistical significance
  2. Abbreviations: CAPA, COVID-19-associated pulmonary aspergillosis; HIV, human immunodeficiency virus